
News|Articles|August 1, 2003
Estrogen plus progestin therapy increases the risk for probable dementia
Estrogen plus progestin therapy does not prevent mild cognitive impairment (MCI) in women aged 65 years and older, and it increases the risk for probable dementia in this group, according to researchers from the Women's Health Initiative Memory Study (WHIMS).
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Celiac Disease and Thyroid Disease in Adolescence Linked to the Development of Type 1 Diabetes in Adulthood
2
Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems
3
Insights from the AMCP Nexus 2025 Meeting
4
Consensus Guidelines for NGS in Sarcoma Diagnosis, Treatment
5

















































